Sarepta Therapeutics, Inc.

( )
SRPT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -0.19%64.850.0%$1003.71m
NVAXNovavax, Inc. -1.68%94.68102.0%$763.63m
AMGNAmgen, Inc. -0.35%250.781.3%$715.90m
REGNRegeneron Pharmaceuticals, Inc. -0.28%638.872.5%$681.09m
GILDGilead Sciences, Inc. 0.05%74.751.0%$611.58m
BIIBBiogen, Inc. -0.53%278.701.6%$607.56m
VRTXVertex Pharmaceuticals, Inc. -0.18%295.401.9%$486.49m
ILMNIllumina, Inc. 0.74%372.603.5%$306.35m
VXRTVaxart, Inc. -0.86%8.120.0%$288.95m
ALXNAlexion Pharmaceuticals, Inc. 0.44%108.472.0%$218.11m
BMRNBioMarin Pharmaceutical, Inc. -1.49%126.814.3%$211.40m
SGENSeattle Genetics, Inc. 3.21%181.176.1%$205.65m
SRNESorrento Therapeutics, Inc. 1.29%7.851.8%$183.25m
IMMUImmunomedics, Inc. 1.81%42.3011.0%$182.18m
ALNYAlnylam Pharmaceuticals, Inc. -0.87%159.038.5%$162.24m

Company Profile

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.